美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi NVO 2x Daily ETF

18.62

-0.9367-4.79%

盤後：19.560.9367+5.03%16:10 EDT

成交量：11

成交額：207

市值：27.94萬

市盈率：- -

高：18.62

開：19.56

低：18.62

收：19.56

52周最高：27.19

52周最低：18.62

股本：1.50萬

流通股本：1.50萬

量比：0.34

換手率：0.07%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

韓國上半年查獲非法進口減重藥物為去年全年三倍

減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？

30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨

Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升

韓國加強單一股票槓桿ETF監管產品成交量縮水至十分之一

美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥

國產藥加速追趕減重明星賽道進入「群雄逐鹿」時代

韓國收緊單一股票槓桿監管後大量投資者轉投美國槓桿ETF

环球市场播报

韓國收緊單一股票槓桿監管後大量投資者轉投美國槓桿ETF

安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發

环球市场播报

Tradr ETFs推出兩隻掛鈎SK海力士（SKHY）單一股票槓桿

減肥藥重走PD-1老路，「白菜價藥王」要來？

韓國金融委員會提前落地單一股票槓桿 ETF 監管新規

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/NVOC/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","market":"US","secType":"STK","nameCN":"Corgi NVO 2x Daily ETF","latestPrice":18.6239,"timestamp":1789156800000,"preClose":19.5606,"halted":0,"volume":11,"hourTrading":{"tag":"盘后","latestPrice":19.5606,"preClose":18.6239,"latestTime":"16:10 EDT","volume":4,"amount":74.4956,"timestamp":1789157404751,"change":0.9367,"changeRate":0.050296,"amplitude":0},"delay":0,"changeRate":-0.047887079128452185,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"休市中","change":-0.9367,"latestTime":"09-11 16:00:00 EDT","open":19.5606,"high":18.6239,"low":18.6239,"amount":207,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1784001600000,"exchange":"CBOE","adjPreClose":19.5606,"nav":19.51,"aum":292650,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":19.5606,"preClose":18.6239,"latestTime":"16:10 EDT","volume":4,"amount":74.4956,"timestamp":1789157404751,"change":0.9367,"changeRate":0.050296,"amplitude":0},"volumeRatio":0.3437511816446869},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3437511816446869,"shares":15000,"dividePrice":0,"high":18.6239,"amplitude":0,"preClose":19.5606,"low":18.6239,"week52Low":18.6239,"pbRate":"--","week52High":27.1863,"institutionHeld":0,"latestPrice":18.6239,"eps":0,"divideRate":0,"volume":11,"delay":0,"ttmEps":0,"open":19.5606,"prevYearClose":24.92,"prevWeekClose":21.8898,"prevMonthClose":20.8451,"prevQuarterClose":24.92,"fiveDayClose":22.7613,"twentyDayClose":21.9066},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOC\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661242360","title":"韓國上半年查獲非法進口減重藥物為去年全年三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661242360","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661242360?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 09:59","pubTimestamp":1787536781,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","NVOC","NVOH","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RSPH","TRUH","FXH","IYH","CURE","PJP","THNR","PINK","NBDS","FHLC","XLVI","MEDI","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FXH","IYH","CURE","TRUH","NBDS","BK4144","PINK","MEDI","PJP","RSPH","NVOC","GLP","THNR","JDOC","FHLC","XLVI","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969925?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDI","TRUH","XLVI","IYH","PINK","PJP","FXH","THNR","NVOC","NBDS","FHLC","RSPH","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644961","title":"韓國加強單一股票槓桿ETF監管 產品成交量縮水至十分之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644961","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644961?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 22:26","pubTimestamp":1786112818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOC","ADVX","MUZ","MULL","MUU","AXTX","MUD","MUYY","MIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657896386?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BZ1G4Q59.USD","KBWB","JDOC","LU0130103400.USD","BAC","LU0211331839.USD","BK4534","IYG","LU0980610538.SGD","LU1506573853.SGD","VFH","IE00B19Z3B42.SGD","TFNS","LLYZ","IE0001KFT4U8.USD","ELIS","OZEM","ELIL","FTXO","FXH","MEDI","LU0314106906.USD","BK4590","GLP","RSPH","TRUH","XLVI","LLII","NBDS","CURE","LU1280957306.USD","FHLC","LU1496350171.SGD","LU0106831901.USD","LU0170899867.USD","UYG","PGF","FNCL","IYF","PINK","XLF","BK4588","IE00BBT3K403.USD","IYH","LU0053666078.USD","NVOC","THNR","LLYX","PJP","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547441","title":"國產藥加速追趕 減重明星賽道進入「群雄逐鹿」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547441","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935232,"startTime":"0","endTime":"0","summary":"新华财经上海8月5日电2026年，我国“体重管理年”三年行动进入收官之年。当前，全民体重管理意识和技能显著提升，健康生活方式更加普及，部分人群体重异常状况得到改善。体重管理催生了减重经济。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832808212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832808212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RSPH","JDOC","NVOH","THNR","NVOX","NVOC","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519388","title":"韓國收緊單一股票槓桿監管後 大量投資者轉投美國槓桿ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519388","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519388?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:39","pubTimestamp":1785915540,"startTime":"0","endTime":"0","summary":"韩国政府加强对单一股票杠杆交易所交易基金的投资监管后，韩国投资者资金正在快速转向美国杠杆ETF。崇实大学会计学系教授孙在成表示：“此次监管虽然是为了保护投资者，但由于是在损失已经发生后出台，因此具有较强的事后补救性质。韩国单一股票杠杆ETF波动性过高，而美国市场相对稳定，因此投资者转向海外杠杆ETF是自然现象。”","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimhawf5184114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MUU","MGKX","QTOC","AVS","EO","MUYY","AVGG","AXTX","AVGW","AVGU","QNTU","NVOC","AVL","MIC","MUZ","UMDD","MUD","AVGX","UCC","MULL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657845519","title":"韓國收緊單一股票槓桿監管後 大量投資者轉投美國槓桿ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2657845519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657845519?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:34","pubTimestamp":1785915262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MUZ","MGKX","AVGG","AVGU","MULL","AVGX","AXTX","QTOC","UMDD","AVS","MIC","MUD","MUU","UCC","MUYY","QNTU","AVL","EO","AVGW","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657674945?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"fut","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1571399168.USD","IE00BFTCPJ56.SGD","XLVI","PJP","LU2242646821.SGD","BK4566","BBH","LU2242652126.USD","IYH","LU0320765992.SGD","FHLC","LU0889565916.HKD","RSPH","NBDS","IE00BJJMRZ35.SGD","LU2089984988.USD","PBE","FXH","IBB","BK4588","IBBQ","BK4581","LU0868494617.USD","PINK","TRUH","LU1983299246.USD","BK4534","MEDI","IE0009355771.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1061106388.HKD","LU0109394709.USD","TBXU","THNR","AMGN","SG9999001440.SGD","IE0002141913.USD","LU0122379950.USD","IE00B4R5TH58.HKD","NVOC","BIB","LU0058720904.USD","BK4533","BK4139","LU0289739699.SGD","IE00B2B36J28.USD","BK4599","CURE","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004625","title":"Tradr ETFs推出兩隻掛鈎SK海力士（SKHY）單一股票槓桿","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004625?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 20:13","pubTimestamp":1785240799,"startTime":"0","endTime":"0","summary":"金吾财讯 | ETF发行商Tradr ETFs推出两只单一股票杠杆ETF，提供针对SK海力士（SKHY）的双向杠杆交易工具，基金将于CBOE交易所上市交易。两只产品分别为 Tradr 2X Short SK hynix Daily ETF（SKHA）以及Tradr 2X Long SK hynix Daily ETF（SKHN）。Tradr ETFs产品与资本市场负责人Matt Markiewicz表示，借助SKHA与SKHN，交易者可通过ETF工具表达对SK海力士及存储器行业周期看涨、看空观点，无需开立保证金账户或交易期权。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDZ","MULL","RAM","SKHU","MIC","SKHYV","MUD","BCDF","MUZ","SK","MUU","BK4532","AXTX","NVOC","SKHZ","BK4588","SKDD","SKUU","HYNX","DRAL","EEMO","CBOE","SKHX","07709","BK4112","BK4141","MUYY","SKHY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653874827","title":"減肥藥重走PD-1老路，「白菜價藥王」要來？","url":"https://stock-news.laohu8.com/highlight/detail?id=2653874827","media":"健康凯歌","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653874827?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 09:23","pubTimestamp":1784683395,"startTime":"0","endTime":"0","summary":"一场减重大战，即将来临。走GCG/GLP-1双靶点路线的玛仕度肽，9毫克组60周减掉了18.55%。研究显示，80周最高剂量组减重28.3%，BMI≥35的对照组，104周减重甚至到了30.3%。此外，医保几轮谈判下来，PD-1的年治疗费用已经不要3万元，这已经不能单纯的算是降价了。疗效类似，再牛的“药王”也扛不住降价的仿制药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8uwIsXpkDir","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["TRUH","RSPH","BK4023","IYH","LU1169589451.USD","PINK","CURE","NVOC","MEDI","NBDS","FXH","FHLC","XLVI","PD","THNR","LU1169590202.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653227932","title":"韓國金融委員會提前落地單一股票槓桿 ETF 監管新規","url":"https://stock-news.laohu8.com/highlight/detail?id=2653227932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653227932?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 16:18","pubTimestamp":1784621901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","MUZ","MUYY","NVOC","FDN","MUU","BK4585","AXTX","MIC","MULL","MUD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":53,"code":"91000000","status":"200"}]}}